From: Efficacy analysis of minimally invasive surgery for Raynaud’s syndrome
Variable | Experimental Group | Control Group |
---|---|---|
Demographics | ||
Number of Participants | 15 | 15 |
Age (mean ± SD) | 49.0 ± 12.2 years | 49.3 ± 13.9 years |
Male, n (%) | 6 (40%) | 8 (53.3%) |
Female, n (%) | 9 (60%) | 7 (46.7%) |
Clinical Data | ||
Duration of Symptoms (mean ± SD) | 9.47 ± 0.31 min | 19.33 ± 1.79 min |
RS Severity Score (mean ± SD) | 8.55 | 11.23 |